15% OFF $150+· CodeFALL15
Ends October 15Shop now
Lot certificates published
Discreet shipping
Catalog/ARA-290 (Cibinetide)
ARA-290 (Cibinetide)
#1044
Lyophilized Peptide

ARA-290 (Cibinetide) 10mg

ARA-290 (cibinetide) is a synthetic 11-amino-acid peptide corresponding to the helix-B surface region of erythropoietin (EPO), bearing an N-terminal pyroglutamate. The pyroglutamate is definitional rather than incidental: the free-glutamine parent peptide (HBSP, CAS 924902-90-9) is a separate compound, and cibinetide / CAS 1208243-50-8 denotes specifically the cyclized pyroglutamate form (pHBSP). It is a non-erythropoietic, non-hematopoietic EPO derivative that selectively engages the innate repair receptor (IRR) — the heteromeric EPO-receptor / β-common-receptor (EPOR-βcR) complex — without stimulating erythropoiesis, making it a tool for isolating the tissue-protective arm of EPO signaling. Supplied strictly for in-vitro research and laboratory use only. Not for human or animal use.

Select Option

Single (10mg)$69.90

2+ save 5% · 5+ save 10% · 10+ save 20%

Quantity

1
= $69.90
Buy now
  • Free Priority shipping on US orders over $100
  • Ships same day on orders before 2 PM MST
  • Discreet, unmarked packaging
  • Certificates published per tested lot — see current coverage

Mechanism of Action

ARA-290 selectively activates the innate repair receptor (EPOR-βcR complex) expressed in response to injury and metabolic stress, without binding the homodimeric EPO receptor that drives red-cell production. IRR activation engages pro-survival signaling (Akt, eNOS), modulates VEGF, and attenuates pro-inflammatory cytokine expression (IL-1β, TNF-α) in preclinical injury models, dissociating tissue-protective signaling from the erythropoietic effects of native EPO.

Properties

CAS Number

1208243-50-8

Molecular Formula

C₅₁H₈₄N₁₆O₂₁

Molecular Weight

1257.32 Da

Sequence

pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser

Half-Life

~2 minutes (rapid plasma clearance; preclinical)

Storage

Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 14 days.

Shipping & Delivery

  • Same-day dispatch on orders placed before 2 PM MST (Arizona — no daylight saving).
  • US shipping from $5. Free Priority on orders $100+ (before discounts).
  • Plain, unmarked packaging — no branding or product names on the outside.
  • Ships to all 50 states, DC, Puerto Rico & the U.S. Virgin Islands; tracking emailed on every order.
Full shipping details

Quality & Testing

  • No third-party certificate has been published for this compound yet.
  • USA-based; dispatched from Phoenix, Arizona.
  • Supplied strictly for in-vitro laboratory research — not for human use.

Certificates are published for each lot we have tested — see the 14 published so far.

Research Applications

1Innate repair receptor (EPOR-βcR) signaling studies
2Non-erythropoietic EPO derivative pharmacology
3Anti-inflammatory and tissue-protection injury models
4Akt/eNOS pro-survival pathway research
5Neuropathic and ischemic tissue models

References & Citations

(3)
1

Activation of the EPOR-β common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes

Bitto A, Irrera N, Pizzino G, et al.

Biochim Biophys Acta Mol Basis Dis (2017)PMID: 29223734 DOI
2

The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic

O'Leary OE, Canning P, Reid E, et al.

Exp Eye Res (2019)PMID: 30876881 DOI
3

Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand

Yao M, Watanabe M, Sun S, et al.

Transplantation (2020)PMID: 32345869 DOI

Research Use Only

This product is intended strictly for in-vitro research, educational, and laboratory use. Not for human consumption. The information provided is based on published research and does not constitute medical advice.

Research reference

A published identity, mechanism, and bibliography record corresponds to this catalog entry.

Research reference: ARA-290